- Release Date: 30/10/13 10:21
- Summary: Orphan drug designation from FDA for NNZ-2566 in Fragile X
- Price Sensitive: Yes
- Download Document 99.4KB
- Forums
- ASX - By Stock
- NEU
- Ann: Orphan drug designation from FDA for NNZ-256
NEU
neuren pharmaceuticals limited
Add to My Watchlist
1.21%
!
$17.57

Ann: Orphan drug designation from FDA for NNZ-256
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$17.57 |
Change
-0.215(1.21%) |
Mkt cap ! $2.221B |
Open | High | Low | Value | Volume |
$17.67 | $18.02 | $17.55 | $6.124M | 345.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
11 | 438 | $17.56 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$17.57 | 2037 | 14 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
12 | 466 | 17.560 |
17 | 6761 | 17.550 |
3 | 767 | 17.540 |
12 | 1159 | 17.530 |
7 | 1611 | 17.520 |
Price($) | Vol. | No. |
---|---|---|
17.570 | 2038 | 15 |
17.580 | 1529 | 10 |
17.590 | 2161 | 15 |
17.600 | 2112 | 20 |
17.610 | 1492 | 10 |
Last trade - 15.09pm 11/08/2025 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |
The Watchlist
WIN
WIN METALS LTD
Steve Norregard, CEO & MD
Steve Norregard
CEO & MD
SPONSORED BY The Market Online